Lv1
40 积分 2025-09-01 加入
Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
30天前
已完结
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial
1个月前
已完结
Efficacy and Safety of the Combination of Tislelizumab with Chemoradiotherapy in Oligorecurrence Esophageal Squamous Cell Carcinoma: A Prospective Phase II Study
1个月前
已完结
Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study
1个月前
已完结
Recent advances in otolaryngology
1个月前
已关闭
Treatment Strategies for Locoregional Recurrence in Esophageal Squamous-Cell Carcinoma: An Updated Review
2个月前
已完结
A Pathologic Classification Approach in Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy: Distinguishing Postoperative Outcomes and Exploring the Potential Benefit of Adjuvant Therapy
2个月前
已完结
皖公网安备34019202002308
